Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 31, 2021

View Archived Issues

CCR6 antagonist PF-07054894 for autoimmune disorders

International researchers discover first nonhormonal treatment target for endometriosis

Increased atrial proarrhythmic activity seen in murine model of OSA

Janssen Biotech divulges DHODH inhibitors

Mindset Pharma patents 5-HT2A receptor agonists

TroBio Therapeutics presents new compounds for cancer

U.K. researchers synthesize new antifungals

New benzimidazole derivative as a selective RORgamma inverse agonist for prostate cancer treatment

Scientists discover and characterize a selective hCYP11B2 PET tracer for primary hyperaldosteronism

New heart failure animal model also captures arrhythmia susceptibility

Low-dose targeted radionuclide therapy using [90Y]NM-600 promotes response to ICIs

New class of Mcl-1 inhibitors developed at Janssen for treating myeloma

Investigators identify new gene mutations behind hereditary optic neuropathy

Preclinical data highlight CAN-04 mode of action in potentiating efficacy of docetaxel

Genexine divulges new anti-PD-L1 fusion proteins

Satellos determines high-resolution crystal structure of target for Duchenne muscular dystrophy

Sonnet selects SON-1410 as development candidate for melanoma and renal cancers

Type of RPE65 variant is associated with age at onset of inherited retinal dystrophies

New genes identified to cause nonsyndromic cleft palate

Polymorphisms in the IRAK2 gene are associated with RA susceptibility

hsa-miR-34b-5p as novel diagnostic marker in male infertility

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.